Under construction – not a live service
Sign in
Enrolling by invitationNo phase

The Effectiveness of Augmented Reality to Enhance CPAP Therapy in OSA Patients

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
National Cheng-Kung University Hospital
Trial code
NCT06520592
Record updated
15 October 2026
Original description
The goal of this clinical trial is to exam if artificial reality works to improve continuous positive airway pressure (CPAP) adherence in obstructive sleep apnea (OSA) patients. It will also learn about the feasibility of AR guided CPAP therapy. The main questions it aims to answer are:Read full original descriptionShow less

Using Augmented Reality to Establish and Evaluate the Effectiveness of a Set of Continuous Positive Airway Pressure Care Management Protocol for Obstructive Sleep Apnea Patients

The goal of this clinical trial is to exam if artificial reality works to improve continuous positive airway pressure (CPAP) adherence in obstructive sleep apnea (OSA) patients. It will also learn about the feasibility of AR guided CPAP therapy. The main questions it aims to answer are:

Does AR guided CPAP therapy increase the adherence of CPAP therapy among OSA patients? What barriers do participants have when using AR guided CPAP therapy? Researchers will compare AR guided CPAP therapy to a control (standard of care) to see if AR guided CPAP therapy works to enhance the adherence of CPAP therapy.

Participants will:

1. Take AR guided CPAP therapy or standard of care every day for 6 months 2. Visit the clinic on baseline (t0), receiving CPAP therapy at the 1st month (t1), for checkups and tests, receiving CPAP therapy at the 3rd month (t2), receiving CPAP therapy at the 6th month (t3). 3. Response their symptoms on each following time.

Inclusion: (1) Diagnosed with moderate to severe obstructive sleep apnea (AHI≥15) through polysomnography (PSG); (2) Age is equal to or greater than 20 years old or equal.

Exclusion: (1) individuals who have previously used positive pressure ventilators for treatment,; (3) those with uncontrolled acute mental illness,; (2) those diagnosed with central sleep apnea,; (4) terminally ill patients.

ClinicalTrials.gov NCT06520592